Atorvastatin Effect on Reduction of COPD Exacerbations — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Atorvastatin Effect on Reduction of COPD Exacerbations — Stella

View on ClinicalTrials.gov

Recruiting

Back to Copd trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Poland

Medical University Hospital, Bialystok

Key details

Phase

Post-approval study

Sponsor

Medical University of Bialystok

Collaborators

Medical Research Agency, Poland

Enrollment target

~460 participants

Started

February 2022

Primary completion

December 2026

Age range

40 Years – 99 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.